印度的皮膚填充劑市場評估:各產品類型，各用途，各成分，各終端用戶，各地區，機會，預測，2018年～2032年

印度真皮填充劑市場預計將從 2024 年的 1.3146 億美元增長到 2032 年的 3.2549 億美元，在預測期內（2025-2032 年）的複合年增長率為 12%。

在美容皮膚科領域，皮膚填充劑是一種可注射材料，旨在增加特定皮膚區域的體積，以減少眼瞼下垂、細紋和皺紋的出現。真皮填充劑通常由膠原蛋白、透明質酸或合成物質製成，旨在使皮膚看起來更年輕。這種非侵入性美容手術由於其能有效治療老化跡象而越來越受歡迎。這是一種短期解決方案，可讓您擁有更清新的外表，而無需忍受手術後通常伴隨的恢復期。許多因素正在嚴重影響印度皮膚填充劑產業。顧客對美容的認識不斷增強，並且喜歡微創手術，這推動了需求的成長。產品配方的改進也使該行業受益匪淺，確保了產品效果更加持久、更自然。此外，人口老化和消費能力的提高推動了對抗老化產品的需求，這也是該產業發展的推動因素。全球美容手術的可及性和可接受性的提高是推動皮膚填充劑市場穩步增長的關鍵因素。

例如，2022 年 8 月，Allergan Aesthetics plc（AbbVie Inc. 的一部分）在印度推出了 Juvederm VOLUX，一種專為下顎線和下巴製造的透明質酸真皮填充劑。 VOLUX 是 25 毫克透明質酸 + 3 毫克鹽酸利多卡因的組合，專為下巴和下顎線使用而設計。

目錄

第1章 計劃的範圍和定義

第2章 調查手法

第3章 摘要整理

第4章 印度的皮膚填充劑市場展望，2018年～2032年

• 市場規模的分析與預測
  • 各金額
  • 各數量
• 市場佔有率分析與預測
  • 各產品類型
    • 生物分解性
    • 沒有生物分解性
  • 各用途
    • 臉部線條矯正
    • 豐唇
    • 整容
    • 痤瘡疤痕的治療
    • 其他
  • 各材料
    • 玻尿酸
    • 烴基磷灰石鈣
    • 聚左旋乳酸
    • 其他
  • 各終端用戶
    • 專門皮膚科診所
    • 醫院·診療所
    • 其他
  • 各地區
    • 北部
    • 南部
    • 東部
    • 西部·中部
    • 各企業市場佔有率分析(前五名公司和其他-各金額，2024年)
• 市場地圖分析，2024年
  • 各產品類型
  • 各用途
  • 各材料
  • 各終端用戶
  • 各地區

所有市場區隔均提供全部對象地區和國家。

第5章 需求供給分析

第6章 價值鏈分析

第7章 波特的五力分析

第8章 大環境分析

第9章 價格分析

第10章 市場動態

• 推動市場要素
• 市場課題

第11章 市場趨勢與發展

第12章 法規結構和革新

• 臨床試驗(世界)
• 法規當局的認證

第13章 專利的形勢

第14章 案例研究

第15章 競爭情形

• 前五名市場領導公司的競爭矩陣
• to前五大企業的SWOT分析
• 前十名市場主要企業的形勢
  • Galderma SA
  • 公司概要
  • 主要經營團隊
  • 產品和服務
  • 財務狀況(如報告)
  • 主要市場焦點和地理存在感
  • 最近的趨勢/合作/夥伴關係/合併和收購
  • Bioplus Co., Ltd.
  • Prollenium Medical Technologies Inc.
  • BIOXIS Pharmaceuticals SAS
  • Sinclair, Inc.
  • Allergan Aesthetics plc(AbbVie Inc.)
  • Dr. Korman Laboratories Ltd.
  • Zhejiang Jingjia Medical Technology Co., Ltd.
  • Medytox Inc.
  • SciVision Biotech Inc.

上述公司不依市場佔有率排序，並且可能會根據研究工作期間獲得的資訊進行更改。

第16章 策略性建議

第17章 關於查公司·免責聲明

India dermal fillers market is projected to witness a CAGR of 12% during the forecast period FY2025-FY2032, growing from USD 131.46 million in FY2024 to USD 325.49 million in FY2032.

In the field of cosmetic dermatology, dermal fillers are injectable materials intended to raise the volume of certain skin regions to lessen the appearance of drooping, fine lines, and wrinkles. Dermal fillers, which are usually made of collagen, hyaluronic acid, or synthetic materials, are intended to give a youthful appearance. The efficacy of this non-invasive cosmetic procedure in treating signs of ageing has led to its increasing popularity. It gives patients a short-term way to seem more refreshed without having to endure the recuperation period typically associated with surgery. Numerous factors have a major impact on the India dermal filler industry. Customers' growing aesthetic consciousness and preference for minimally invasive procedures have led to an increase in demand. The industry also benefits from improvements in product compositions that guarantee longer-lasting and seemingly natural results. Moreover, ageing population coupled with growing expenditure capacity, has led the demand for anti-aging products, is another factor driving the industry. The increasing accessibility and acceptance of beauty-enhancing procedures around the world are major factors propelling the dermal fillers market towards a trajectory of stable growth.

For example, in August 2022, Allergan Aesthetics plc (part of AbbVie Inc.) introduced Juvederm VOLUX, a hyaluronic acid dermal filler created especially for the jawline and chin in India. VOLUX is a combination of Hyaluronic acid 25 mg + Lidocaine hydrochloride 3 mg, specifically designed for use in the chin and jawline.

Rising Consumer Awareness Boosting the Market Growth

The market for dermal fillers is expanding rapidly due to recent developments in India. Perception of cosmetic procedures is changing as a result of the growing acceptability of aesthetic treatments, especially among younger consumers. Dermal fillers have become increasingly popular as more people look for non-surgical ways to improve their faces. This trend has been aided by the growth of cosmetic clinics and medical spas in cities. Improvements in safety and efficacy brought about by technological developments in filler formulations, particularly those based on hyaluronic acid, have increased the appeal of these procedures. Furthermore, social media platforms have been playing important part in normalising cosmetic operations and persuading people that dermal fillers are a good way to improve their appearance. This tendency has been further stimulated by the growth of a middle class with more discretionary income, which enables more people to spend money on cosmetic improvements. Additionally, India's standing as a medical tourism destination is drawing in foreign patients looking for premium care at affordable costs. These elements, together with calculated partnerships between producers and clinics, are fostering a thriving dermal fillers market in India and setting it up for future growth. According to the International Society of Aesthetic Plastic Surgery data published in 2023, a total of 222,544 non-surgical injectable procedures performed in India, a significant increase from just 90,384 in 2020.

Recent Advancements to Fuel Market Growth

Advances in filler compositions, such as the advent of hyaluronic acid-based fillers with varying degrees of cross-linking, have changed the available treatment choices. Professionals can now customize their treatments to yield better, longer-lasting benefits thanks to these advancements. For instance, new biodegradable and bioresorbable fillers address sustainability concerns and appeal to environmentally conscious consumers. Additionally, the administration of dermal fillers is now more accurate and effective due to the use of advanced injectable procedures, which also shorten recovery times and minimize patient discomfort. The rise in minimally invasive procedures has further boosted demand as more people search for non-surgical options for aesthetic improvements. Furthermore, as research and development continue, projects are broadening the range of dermal filler treatments beyond conventional ones like wrinkle treatment and lip augmentation to include volume restoration and facial contouring. This continuous innovation not only drives market growth but also enhances consumer confidence in aesthetic procedures, solidifying the role of technology as a key factor in the dermal fillers market expansion. For instance, in December 2022, Gufic Biosciences Ltd. introduced a locally produced injection of botulinum toxin type A (Botox) in India. In India, Gufic Biosciences Ltd's botox will be marketed under the name "Zarbot." According to the company, one of "Zarbot's" key characteristics is that it was produced utilizing a patented method and refined strain, which leads to a thin film formulation and superior stability when compared to other botulinum toxin brands.

Influencers and Celebrities Fueling Market Growth

The market for dermal fillers in India is being driven largely by celebrities and influencers, who also have a big impact on how the general public views and accepts cosmetic operations. Prominent people who freely talk about their experiences with fillers normalize these procedures and inspire admirers to think about getting similar improvements. Their openness about their personal preferences for aesthetic changes promotes a society in which cosmetic surgery is no longer seen as taboo but rather as a way to better oneself. Fans may closely monitor the beauty modifications of their favourite celebrities through social media channels, which magnify this influence. Nowadays, a lot of people want to look like celebrities, asking for particular traits that match the style that these giants have made popular. Not just women are following this trend; male celebrities are also changing how people view beauty and masculinity, which increases the market's attractiveness. 'Additionally, as filler debates gain traction, specialists are addressing worries regarding safety and natural outcomes, which reassures prospective customers even more. Celebrity endorsements and growing consumer awareness are driving India's dermal fillers business, increasing accessibility and acceptance of aesthetic modifications across a range of demographics.

Future Market Scenario (FY2025 - FY2032F)

The dermal filler market is set to grow because of new developments in technology, life sciences, and materials research. There is a rising need for non-invasive treatments, that will boost innovation.

Furthermore, technological advancements like AI integration in laser devices are changing the field by improving image analysis and making research processes faster, which greatly supports market growth. Other than this, innovations are the supporting pillars of this ever-growing market. For instance, the Profhilo injectable therapy is a novel cosmetic procedure that has swept the beauty industry in India off its feet. Often referred to as the "injectable moisturizer," this treatment has grown in favor among those who want to look younger, more radiant, and refreshed without undergoing invasive treatments. Profhilo adopts a novel strategy by hydrating the skin from the inside out, in contrast to conventional dermal fillers, which seek to reduce wrinkles and increase volume.

Key Players Landscape and Outlook

Key players in the dermal fillers industry are utilizing strategies such as mergers, acquisitions, partnerships, and new product launches to improve their services and competitiveness. Such efforts will propel significant growth in the market, allowing big-cap industry players to increase their presence and, therefore, find new opportunities in this market.

For instance, in October 2023, A. Menarini India Private Limited (often called "Menarini India"), a part of the Menarini Group, the biggest Italian biopharmaceutical company in the world and a pioneer in dermatological and cosmetics treatments, announced its entry into the Indian aesthetics market. Through a combination of specialized, well-made products and procedures, Menarini and RELIFE, which have their main offices in Italy, provide aesthetic physicians and surgeons with a holistic approach to cosmetic medicine to assist patients in attaining effortlessly beautiful skin.

For instance, in an effort to develop powerful instruments that provide the best outcomes for practitioners and patients, Prollenium Medical Technologies Inc. announced in October 2023 that it has acquired SoftFil medical devices.

Table of Contents

1. Project Scope and Definitions

2. Research Methodology

3. Executive Summary

4. India Dermal Fillers Market Outlook, FY2018-FY2032F

• 4.1. Market Size Analysis & Forecast
  • 4.1.1. By Value
  • 4.1.2. By Volume
• 4.2. Market Share Analysis & Forecast
  • 4.2.1. By Product Type
    • 4.2.1.1. Biodegradable
    • 4.2.1.2. Non-Biodegradable
  • 4.2.2. By Application
    • 4.2.2.1. Facial Line Correction
    • 4.2.2.2. Lip Augmentation
    • 4.2.2.3. Face Lift
    • 4.2.2.4. Acne Scar Treatment
    • 4.2.2.5. Others
  • 4.2.3. By Ingredients
    • 4.2.3.1. Hyaluronic Acid
    • 4.2.3.2. Calcium Hydroxylapatite
    • 4.2.3.3. Poly-L-Lactic Acid
    • 4.2.3.4. Others
  • 4.2.4. By End-user
    • 4.2.4.1. Specialty Dermatology Clinics
    • 4.2.4.2. Hospitals and Clinics
    • 4.2.4.3. Others
  • 4.2.5. By Region
    • 4.2.5.1. North
    • 4.2.5.2. South
    • 4.2.5.3. East
    • 4.2.5.4. West and Central
    • 4.2.5.5. By Company Market Share Analysis (Top 5 Companies and Others - By Value, FY2024)
• 4.3. Market Map Analysis, FY2024
  • 4.3.1. By Product Type
  • 4.3.2. By Application
  • 4.3.3. By Ingredients
  • 4.3.4. By End-user
  • 4.3.5. By Region

All segments will be provided for all regions and countries covered

5. Demand Supply Analysis

6. Value Chain Analysis

7. Porter's Five Forces Analysis

8. PESTLE Analysis

9. Pricing Analysis

10. Market Dynamics

• 10.1. Market Drivers
• 10.2. Market Challenges

11. Market Trends and Developments

12. Regulatory Framework and Innovation

• 12.1. Clinical Trials (Global)
• 12.2. Regulatory Approvals

13. Patent Landscape

14. Case Studies

15. Competitive Landscape

• 15.1. Competition Matrix of Top 5 Market Leaders
• 15.2. SWOT Analysis for Top 5 Players
• 15.3. Key Players Landscape for Top 10 Market Players
  • 15.3.1. Galderma SA
    • 15.3.1.1. Company Details
    • 15.3.1.2. Key Management Personnel
    • 15.3.1.3. Products and Services
    • 15.3.1.4. Financials (As Reported)
    • 15.3.1.5. Key Market Focus and Geographical Presence
    • 15.3.1.6. Recent Developments/Collaborations/Partnerships/Mergers and Acquisition
  • 15.3.2. Bioplus Co., Ltd.
  • 15.3.3. Prollenium Medical Technologies Inc.
  • 15.3.4. BIOXIS Pharmaceuticals SAS
  • 15.3.5. Sinclair, Inc.
  • 15.3.6. Allergan Aesthetics plc (AbbVie Inc.)
  • 15.3.7. Dr. Korman Laboratories Ltd.
  • 15.3.8. Zhejiang Jingjia Medical Technology Co., Ltd.
  • 15.3.9. Medytox Inc.
  • 15.3.10. SciVision Biotech Inc.

Companies mentioned above DO NOT hold any order as per market share and can be changed as per information available during research work.

16. Strategic Recommendations

17. About Us and Disclaimer

List of Tables

• Table 1. Competition Matrix of Top 5 Market Leaders
• Table 2. Mergers & Acquisitions/ Joint Ventures (If Applicable)
• Table 3. About Us - Regions and Countries Where We Have Executed Client Projects

List of Figures

• Figure 1. India Dermal Fillers Market, By Value, In USD Million, FY2018-FY2032F
• Figure 2. India Dermal Fillers Market, By Volume, In Million Units, FY2018-FY2032F
• Figure 3. India Dermal Fillers Market Share (%), By Product Type, FY2018-FY2032F
• Figure 4. India Dermal Fillers Market Share (%), By Application, FY2018-FY2032F
• Figure 5. India Dermal Fillers Market Share (%), By Ingredients, FY2018-FY2032F
• Figure 6. India Dermal Fillers Market Share (%), By End-user, FY2018-FY2032F
• Figure 7. India Dermal Fillers Market Share (%), By Region, FY2018-FY2032F
• Figure 8. By Product Type Map-Market Size (USD Million) & Growth Rate (%), FY2024
• Figure 9. By Application Map-Market Size (USD Million) & Growth Rate (%), FY2024
• Figure 10. By Ingredients Map-Market Size (USD Million) & Growth Rate (%), FY2024
• Figure 11. By End-user Map-Market Size (USD Million) & Growth Rate (%), FY2024
• Figure 12. By Region Map-Market Size (USD Million) & Growth Rate (%), FY2024